{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:37:53Z","timestamp":1777901873203,"version":"3.51.4"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["D43 TW011532"],"award-info":[{"award-number":["D43 TW011532"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tuberculosis preventive treatment (TPT) is crucial for reducing tuberculosis (TB) incidence and related mortality among people with human immunodeficiency virus (HIV); however, its implementation in Georgia faces challenges. In this study, we aimed to explore the TPT care cascade among people with HIV (PWH) in Georgia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using a mixed-methods approach, we assessed TPT uptake, adherence, and impact on TB development within the 2019\u20132020 cohort of newly diagnosed PWH across 4 major HIV service providers in Georgia. With qualitative analysis under the Consolidated Framework for Implementation Research, we identified barriers and facilitators to its implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 1165 PWH, only 11.8% initiated TPT with isoniazid. Thirty-two developed active TB (incidence rate, 10\/1000 person-years [95% confidence interval, 9.6\u201310.4]), none of whom received TPT. Only 43% of 137 PWH on TPT adhered for 3\u20136 months; 29 (21.1%) completed the full course. The study revealed poor TPT service coordination, worsened by major data limitations. Interviews identified several barriers to effective TPT implementation, summarized into 3 broad categories: the need for TPT service integration into HIV care, the potential development of an integrated electronic data system, and training gaps.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study revealed low TPT coverage among Georgian PWH and significant data gaps. Findings underscore the need to reevaluate the TPT care cascade, emphasizing improved record-keeping and reporting practices through an integrated electronic system. Enhancing access by integrating TPT into HIV care, reducing stigma through streamlined referrals, and strengthening healthcare worker training are critical to increasing TPT uptake and ultimately reducing TB morbidity and mortality among PWH in Georgia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf768","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:08:02Z","timestamp":1765544882000},"source":"Crossref","is-referenced-by-count":1,"title":["Analysis of Tuberculosis Preventive Treatment Cascade Among People With Human Immunodeficiency Virus in Georgia: A Mixed-Methods Study"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8434-1811","authenticated-orcid":false,"given":"Mariana","family":"Buziashvili","sequence":"first","affiliation":[{"name":"Scientific Research Unit, National Center for Tuberculosis and Lung Diseases , Tbilisi ,","place":["Georgia"]},{"name":"Department of Medicine, Tbilisi State University , Tbilisi ,","place":["Georgia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8390-3325","authenticated-orcid":false,"given":"Davit","family":"Baliashvili","sequence":"additional","affiliation":[{"name":"Partnership for Research and Action for Health , Tbilisi ,","place":["Georgia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akaki","family":"Abutidze","sequence":"additional","affiliation":[{"name":"T. Tsertsvadze Infectious Diseases, AIDS and Clinical Immunology Research Center , Tbilisi ,","place":["Georgia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1309-825X","authenticated-orcid":false,"given":"Nikoloz","family":"Chkhartishvili","sequence":"additional","affiliation":[{"name":"T. Tsertsvadze Infectious Diseases, AIDS and Clinical Immunology Research Center , Tbilisi ,","place":["Georgia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0276-1204","authenticated-orcid":false,"given":"Nestani","family":"Tukvadze","sequence":"additional","affiliation":[{"name":"Scientific Research Unit, National Center for Tuberculosis and Lung Diseases , Tbilisi ,","place":["Georgia"]},{"name":"Department of Medicine, Swiss Tropical and Public Health Institute , Allschwil ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3023-1902","authenticated-orcid":false,"given":"Otar","family":"Chokoshvili","sequence":"additional","affiliation":[{"name":"T. Tsertsvadze Infectious Diseases, AIDS and Clinical Immunology Research Center , Tbilisi ,","place":["Georgia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7307-0614","authenticated-orcid":false,"given":"Jack","family":"DeHovitz","sequence":"additional","affiliation":[{"name":"Department of Medicine, State University of New York Downstate Health Sciences University , Brooklyn, New York ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1614-854X","authenticated-orcid":false,"given":"Mamuka","family":"Djibuti","sequence":"additional","affiliation":[{"name":"Partnership for Research and Action for Health , Tbilisi ,","place":["Georgia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"2026010203512284500_ofaf768-B1","doi-asserted-by":"crossref","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"2026010203512284500_ofaf768-B2","author":"World Health Organization"},{"key":"2026010203512284500_ofaf768-B3","doi-asserted-by":"crossref","first-page":"462","DOI":"10.26444\/aaem\/106765","article-title":"Comparative analysis of the effectiveness of tuberculosis prophylaxis in patients with HIV\/AIDS treated with isoniazid","volume":"26","author":"Juszkiewicz","year":"2019","journal-title":"Ann Agric Environ Med"},{"key":"2026010203512284500_ofaf768-B4","doi-asserted-by":"crossref","first-page":"e0266285","DOI":"10.1371\/journal.pone.0266285","article-title":"Incidence of tuberculosis among PLHIV on antiretroviral therapy who initiated isoniazid preventive therapy: a multi-center retrospective cohort study","volume":"17","author":"Kazibwe","year":"2022","journal-title":"PLoS One"},{"key":"2026010203512284500_ofaf768-B5","doi-asserted-by":"crossref","first-page":"e1002464","DOI":"10.1371\/journal.ppat.1002464","article-title":"Tuberculosis and HIV co-infection","volume":"8","author":"Pawlowski","year":"2012","journal-title":"PLoS Pathog"},{"key":"2026010203512284500_ofaf768-B6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5588\/ijtld.18.0207","article-title":"Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries","volume":"23","author":"Harries","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026010203512284500_ofaf768-B7","volume-title":"Global tuberculosis report 2024","author":"World Health Organization","year":"2024"},{"key":"2026010203512284500_ofaf768-B8","volume-title":"Global tuberculosis report 2023","author":"World Health Organization","year":"2023"},{"key":"2026010203512284500_ofaf768-B9","doi-asserted-by":"crossref","first-page":"e1003702","DOI":"10.1371\/journal.pmed.1003702","article-title":"Tuberculosis preventive treatment in people living with HIV\u2014is the glass half empty or half full?","volume":"18","author":"Oxlade","year":"2021","journal-title":"PLoS Med"},{"key":"2026010203512284500_ofaf768-B10","author":"World Health Organization."},{"key":"2026010203512284500_ofaf768-B11","doi-asserted-by":"crossref","first-page":"e25438","DOI":"10.1002\/jia2.25438","article-title":"New opportunities in tuberculosis prevention: implications for people living with HIV","volume":"23","author":"Gonz\u00e1lez Fern\u00e1ndez","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"2026010203512284500_ofaf768-B12","doi-asserted-by":"crossref","first-page":"e0142290","DOI":"10.1371\/journal.pone.0142290","article-title":"Isoniazid prophylactic therapy for the prevention of tuberculosis in HIV infected adults: a systematic review and meta-analysis of randomized trials","volume":"10","author":"Ayele","year":"2015","journal-title":"PLoS One"},{"key":"2026010203512284500_ofaf768-B13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0140-6736(14)60162-8","article-title":"Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial","volume":"384","author":"Rangaka","year":"2014","journal-title":"Lancet"},{"key":"2026010203512284500_ofaf768-B14","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/cid\/ciu849","article-title":"Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: The TB\/HIV in Rio (THRio) study","volume":"60","author":"Golub","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2026010203512284500_ofaf768-B15","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1507198","article-title":"A trial of early antiretrovirals and isoniazid preventive therapy in Africa","volume":"373","author":"TEMPRANO ANRS 12136 Study Group","year":"2015","journal-title":"N Engl J Med"},{"key":"2026010203512284500_ofaf768-B16","doi-asserted-by":"crossref","first-page":"e1080","DOI":"10.1016\/S2214-109X(17)30372-8","article-title":"Effect of isoniazid preventive therapy on risk of death in West African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial","volume":"5","author":"Badje","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2026010203512284500_ofaf768-B17","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.5588\/ijtld.13.0889","article-title":"Review of policy and status of implementation of collaborative HIV-TB activities in 23 high-burden countries","volume":"18","author":"Gupta","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026010203512284500_ofaf768-B18","author":"National Center for Disease Control and Public Health"},{"key":"2026010203512284500_ofaf768-B19","author":"Ministry of Internally Displaces Persons from the Occupied Territories, Labour, Health, and Social Affairs of Georgia"},{"key":"2026010203512284500_ofaf768-B20","doi-asserted-by":"crossref","first-page":"e1000391","DOI":"10.1371\/journal.pmed.1000391","article-title":"Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies","volume":"8","author":"Getahun","year":"2011","journal-title":"PLoS Med"},{"key":"2026010203512284500_ofaf768-B21","volume-title":"WHO operational handbook on tuberculosis. Module 2: screening\u2014systematic screening for tuberculosis disease","author":"World Health Organization.","year":"2021"},{"key":"2026010203512284500_ofaf768-B22","author":"World Health Organization"},{"key":"2026010203512284500_ofaf768-B23","doi-asserted-by":"crossref","first-page":"ofae466","DOI":"10.1093\/ofid\/ofae466","article-title":"Incidence rate and risk factors for developing active tuberculosis among people living with HIV in Georgia 2019\u20132020 cohort","volume":"11","author":"Buziashvili","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026010203512284500_ofaf768-B24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","article-title":"The updated Consolidated Framework for Implementation Research based on user feedback","volume":"17","author":"Damschroder","year":"2022","journal-title":"Implement Sci"},{"key":"2026010203512284500_ofaf768-B25","author":"World Health Organization"},{"key":"2026010203512284500_ofaf768-B26","volume-title":"Global tuberculosis report 2019","author":"World Health Organization","year":"2019"},{"key":"2026010203512284500_ofaf768-B27","volume-title":"Global tuberculosis report 2020","author":"World Health Organization","year":"2020"},{"key":"2026010203512284500_ofaf768-B28","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/cid\/ciaf069","article-title":"Lower tuberculosis incidence among people with HIV who completed isoniazid preventive therapy in Ukraine, a high-burden multidrug-resistant tuberculosis setting: a retrospective cohort study","volume":"81","author":"Sodeke","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026010203512284500_ofaf768-B29","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1186\/s12889-021-10929-z","article-title":"Assessment of the tuberculosis case-finding and prevention cascade among people living with HIV in Zambia\u20142018: a cross-sectional cluster survey","volume":"21","author":"Melgar","year":"2021","journal-title":"BMC Public Health"},{"key":"2026010203512284500_ofaf768-B30","doi-asserted-by":"crossref","first-page":"e0268935","DOI":"10.1371\/journal.pone.0268935","article-title":"Increased uptake of tuberculosis preventive therapy (TPT) among people living with HIV following the 100-days accelerated campaign: a retrospective review of routinely collected data at six urban public health facilities in Uganda","volume":"18","author":"Musaazi","year":"2023","journal-title":"PLoS One"},{"key":"2026010203512284500_ofaf768-B31","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1186\/s12889-020-09902-z","article-title":"Evaluation of the uptake of tuberculosis preventative therapy for people living with HIV in Namibia: a multiple methods analysis","volume":"20","author":"Roscoe","year":"2020","journal-title":"BMC Public Health"},{"key":"2026010203512284500_ofaf768-B32","author":"World Health Organization"},{"key":"2026010203512284500_ofaf768-B33","doi-asserted-by":"crossref","first-page":"e0223076","DOI":"10.1371\/journal.pone.0223076","article-title":"Isoniazid preventive therapy: uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe","volume":"14","author":"Nyathi","year":"2019","journal-title":"PLoS One"},{"key":"2026010203512284500_ofaf768-B34","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijid.2020.11.192","article-title":"Coverage of isoniazid preventive therapy among people living with HIV: a retrospective cohort study in Tanzania (2012\u20132016)","volume":"103","author":"Maokola","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2026010203512284500_ofaf768-B35","doi-asserted-by":"crossref","first-page":"3000605211046133","DOI":"10.1177\/03000605211046133","article-title":"Tuberculosis screening coverage and isoniazid preventive therapy among people living with HIV at Gambella Hospital, southwest Ethiopia: a retrospective study design","volume":"49","author":"Aboma","year":"2021","journal-title":"J Int Med Res"},{"key":"2026010203512284500_ofaf768-B36","doi-asserted-by":"crossref","first-page":"e1003703","DOI":"10.1371\/journal.pmed.1003703","article-title":"The latent tuberculosis cascade-of-care among people living with HIV: a systematic review and meta-analysis","volume":"18","author":"Bastos","year":"2021","journal-title":"PLoS Med"},{"key":"2026010203512284500_ofaf768-B37","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries","volume":"46","author":"Getahun","year":"2015","journal-title":"Eur Respir J"},{"key":"2026010203512284500_ofaf768-B38","author":"World Health Organization"},{"key":"2026010203512284500_ofaf768-B39","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"2026010203512284500_ofaf768-B40","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5588\/ijtld.17.0758","article-title":"TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings","volume":"22","author":"Pathmanathan","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026010203512284500_ofaf768-B41","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.5588\/ijtld.19.0018","article-title":"Policies, practices and barriers to implementing tuberculosis preventive treatment\u201435 countries, 2017","volume":"23","author":"Surie","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026010203512284500_ofaf768-B42","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(10)60483-7","article-title":"Tuberculosis control and elimination 2010\u201350: cure, care, and social development","volume":"375","author":"L\u00f6nnroth","year":"2010","journal-title":"Lancet"},{"key":"2026010203512284500_ofaf768-B43","doi-asserted-by":"crossref","first-page":"388","DOI":"10.5588\/ijtld.20.0956","article-title":"Gaps in TB preventive therapy for persons initiating antiretroviral therapy in Uganda: an explanatory sequential cascade analysis","volume":"25","author":"Kalema","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026010203512284500_ofaf768-B44","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","article-title":"The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis","volume":"16","author":"Alsdurf","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2026010203512284500_ofaf768-B45","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1080\/09540121.2017.1283390","article-title":"\u201cIt's about my life\u201d: facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa","volume":"29","author":"Jacobson","year":"2017","journal-title":"AIDS Care"},{"key":"2026010203512284500_ofaf768-B46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s43058-023-00490-8","article-title":"Healthcare worker perceived barriers and facilitators to implementing a tuberculosis preventive therapy program in rural South Africa: a content analysis using the consolidated framework for implementation research","volume":"4","author":"van de Water","year":"2023","journal-title":"Implement Sci Commun"},{"key":"2026010203512284500_ofaf768-B47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5588\/pha.20.0005","article-title":"Tuberculosis preventive therapy uptake barriers: what are the low-lying fruits to surmount this?","volume":"10","author":"Masini","year":"2020","journal-title":"Public Health Action"},{"key":"2026010203512284500_ofaf768-B48","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.5588\/ijtld.15.0805","article-title":"Predictors of adherence to isoniazid preventive therapy in people living with HIV in Ethiopia","volume":"20","author":"Ayele","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026010203512284500_ofaf768-B49","doi-asserted-by":"crossref","first-page":"e27013","DOI":"10.2196\/27013","article-title":"Collect once, use many times: attaining unified metrics for tuberculosis preventive treatment for people living with HIV","volume":"7","author":"Fukunaga","year":"2021","journal-title":"JMIR Public Health Surveill"},{"key":"2026010203512284500_ofaf768-B50","doi-asserted-by":"crossref","first-page":"1207602","DOI":"10.3389\/fdgth.2023.1207602","article-title":"Exploring the barriers and facilitators to implementing electronic health records in a middle-income country: a qualitative study from South Africa","volume":"5","author":"Zharima","year":"2023","journal-title":"Front Digit Health"},{"key":"2026010203512284500_ofaf768-B51","doi-asserted-by":"crossref","first-page":"e004223","DOI":"10.1136\/bmjgh-2020-004223","article-title":"Interventions to improve district-level routine health data in low-income and middle-income countries: a systematic review","volume":"6","author":"Lee","year":"2021","journal-title":"BMJ Glob Health"},{"key":"2026010203512284500_ofaf768-B52","doi-asserted-by":"crossref","first-page":"e0000312","DOI":"10.1371\/journal.pgph.0000312","article-title":"Assessment of facility-based tuberculosis data quality in an integrated HIV\/TB database in three South African districts","volume":"2","author":"Murphy","year":"2022","journal-title":"PLoS Glob Public Health"},{"key":"2026010203512284500_ofaf768-B53","first-page":"298","article-title":"Tuberculosis preventive treatment (TPT) in India: a qualitative review","volume":"1","author":"Patel","year":"2024","journal-title":"Prev Med Res"},{"key":"2026010203512284500_ofaf768-B54","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5588\/pha.22.0030","article-title":"Reasons for poor uptake of TB preventive therapy in South Africa","volume":"12","author":"Baloyi","year":"2022","journal-title":"Public Health Action"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf768\/65880731\/ofaf768.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/1\/ofaf768\/65880731\/ofaf768.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/1\/ofaf768\/65880731\/ofaf768.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T08:51:34Z","timestamp":1767343894000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf768\/8379946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf768","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,12,15]]},"article-number":"ofaf768"}}